|
?:authorAffiliation
|
-
[\'Guangzhou Laboratory, Guangzhou International Biotech Island, Guangzhou, China.\', \'Innovent Biologics (Suzhou) Co., Ltd., Suzhou, Jiangsu, China.\', \'Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.\', \'State Key Laboratory of Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.\', \'Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.\', \'Department of Infectious Diseases, The Third People\'s Hospital of Changzhou, Changzhou, China.\', \'Department of Medical Oncology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.\', \'Guangzhou Institute of Respiratory Health, Guangzhou, China.\', \'Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\', \'Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.\', \'Department of Thoracic Oncology and Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}